Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 04 10 2018
accepted: 29 11 2018
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 2 10 2020
Statut: epublish

Résumé

Glaucoma is the leading cause of irreversible blindness worldwide and requires regular monitoring upon diagnosis to ascertain whether the disease is stable or progressing. However, making this determination remains a difficult clinical task. Recently, a novel spatiotemporal boundary detection predictor of glaucomatous visual field (VF) progression (STBound) was developed. In this work, we explore the ability of STBound to differentiate progressing and non-progressing glaucoma patients in comparison to existing methods. STBound, Spatial PROGgression, and traditional trend-based progression methods (global index (GI) regression, mean regression slope, point-wise linear regression, permutation of pointwise linear regression) were applied to longitudinal VF data from 191 eyes of 91 glaucoma patients. The ability of each method to identify progression was compared using Akaike information criterion (AIC), full/partial area under the receiver operating characteristic curve (AUC/pAUC), sensitivity, and specificity. STBound offered improved diagnostic ability (AIC: 197.77 vs. 204.11-217.55; AUC: 0.74 vs. 0.63-0.70) and showed no correlation (r: -0.01-0.11; p-values: 0.11-0.93) with the competing methods. STBound combined with GI (the top performing competitor) provided improved performance over all individual metrics and compared to all metrics combined with GI (all p-values < 0.05). STBound may be a valuable diagnostic tool and can be used in conjunction with existing methods.

Identifiants

pubmed: 30874616
doi: 10.1038/s41598-018-37127-z
pii: 10.1038/s41598-018-37127-z
pmc: PMC6420602
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4642

Références

Transl Vis Sci Technol. 2016 Aug 31;5(4):14
pubmed: 27622079
Invest Ophthalmol Vis Sci. 2012 Oct 01;53(11):6776-84
pubmed: 22952123
Am J Ophthalmol. 2012 Oct;154(4):702-11
pubmed: 22835512
Arch Ophthalmol. 2010 Oct;128(10):1249-55
pubmed: 20696979
J Am Stat Assoc. 2019;114(527):1063-1074
pubmed: 31662589
Prog Brain Res. 2015;221:135-58
pubmed: 26518076
Ophthalmology. 2016 Jun;123(6):1170-2
pubmed: 27210598
Am J Ophthalmol. 2008 Feb;145(2):343-53
pubmed: 18078852
Lancet. 2015 Apr 4;385(9975):1295-304
pubmed: 25533656
Ophthalmology. 2008 Sep;115(9):1557-65
pubmed: 18378317
Surv Ophthalmol. 2002 Mar-Apr;47(2):158-73
pubmed: 11918896
PLoS One. 2014 Jan 17;9(1):e85654
pubmed: 24465636
Stat Med. 2017 May 20;36(11):1735-1753
pubmed: 28152571
Ophthalmology. 1995 Aug;102(8):1227-34; discussion 1234-5
pubmed: 9097752
Invest Ophthalmol Vis Sci. 2012 Sep 06;53(10):5985-90
pubmed: 22879418
Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1544-53
pubmed: 23341021
Invest Ophthalmol Vis Sci. 2011 Jun 08;52(7):4030-8
pubmed: 21467169
IEEE Trans Biomed Eng. 2014 Apr;61(4):1143-54
pubmed: 24658239
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):6077-83
pubmed: 26393667
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4600-6
pubmed: 16303955
Ophthalmology. 2007 Nov;114(11):1965-72
pubmed: 17628686
Biometrics. 2003 Sep;59(3):614-23
pubmed: 14601762
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):251-7
pubmed: 17197540
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Vision Res. 2004 Apr;44(8):839-48
pubmed: 14967209
Ophthalmology. 1997 Jul;104(7):1131-7
pubmed: 9224466
Ophthalmology. 2009 Feb;116(2):200-7
pubmed: 19019444
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1419-28
pubmed: 8641844
Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):512-20
pubmed: 2318590
Invest Ophthalmol Vis Sci. 2002 May;43(5):1400-7
pubmed: 11980853
Arch Ophthalmol. 1999 Sep;117(9):1137-42
pubmed: 10496384
Arch Ophthalmol. 2009 Dec;127(12):1610-5
pubmed: 20008716
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904

Auteurs

Samuel I Berchuck (SI)

Department of Statistical Science and Forge, Duke University, Durham, NC, USA.

Jean-Claude Mwanza (JC)

Department of Ophthalmology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

Angelo P Tanna (AP)

Department of Ophthalmology, Northwestern University, Illinois, USA.

Donald L Budenz (DL)

Department of Ophthalmology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

Joshua L Warren (JL)

Department of Biostatistics, Yale University, Connecticut, USA. joshua.warren@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH